Published in Gynecol Oncol on October 23, 2014
The biology of cancer-related fatigue: a review of the literature. Support Care Cancer (2015) 1.02
Effects of infrared laser moxibustion on cancer-related fatigue: A randomized, double-blind, placebo-controlled trial. Cancer (2016) 0.84
Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1β: Investigating a Method for the Study of Fatigue in Laboratory Animals. PLoS One (2015) 0.77
Nordic Walking and the Isa Method for Breast Cancer Survivors: Effects on Upper Limb Circumferences and Total Body Extracellular Water - a Pilot Study. Breast Care (Basel) (2016) 0.75
Physical exercises for breast cancer survivors: effects of 10 weeks of training on upper limb circumferences. J Phys Ther Sci (2016) 0.75
Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study. Support Care Cancer (2016) 0.75
The problem of fatigue in patients suffering from neoplastic disease. Contemp Oncol (Pozn) (2017) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res (1995) 9.99
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer (1999) 7.87
When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain (1995) 5.97
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst (2009) 5.05
Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2005) 3.34
A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp (2008) 3.19
Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. J Clin Oncol (2014) 2.77
Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun (2007) 2.75
Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res (2006) 2.69
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer (2003) 2.48
The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun (2006) 2.40
Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer (2011) 2.18
Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol (2011) 2.05
Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer (2010) 1.97
Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev (2006) 1.84
Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull (2008) 1.82
Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage (2001) 1.76
Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol (2014) 1.71
Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue. Qual Life Res (2006) 1.70
Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol (2003) 1.63
Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol (2006) 1.52
Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol (2007) 1.51
Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst (2013) 1.47
Reliability of adverse symptom event reporting by clinicians. Qual Life Res (2011) 1.45
Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer (2008) 1.43
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol (2006) 1.37
Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist (2007) 1.36
Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun (2010) 1.36
Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes (2007) 1.32
The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology (2007) 1.31
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun (2012) 1.31
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat (2005) 1.24
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage (2010) 1.23
Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer (2014) 1.17
Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial. Psychoneuroendocrinology (2014) 1.13
Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage (2009) 1.12
Cancer-related fatigue. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2007) 1.10
Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs (2008) 1.05
Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst (2010) 1.03
Gene expression correlates of unexplained fatigue. Pharmacogenomics (2006) 1.03
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. Oncologist (2013) 0.99
The basal ganglia: a substrate for fatigue in multiple sclerosis. Neuroradiology (2007) 0.99
Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage (2011) 0.98
An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psychooncology (2006) 0.97
A new way of thinking about fatigue: a reconceptualization. Oncol Nurs Forum (2007) 0.97
Altered circadian rhythms and cancer-related fatigue outcomes. Integr Cancer Ther (2011) 0.93
Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors. Clin J Oncol Nurs (2008) 0.92
Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set. J Pain Symptom Manage (2011) 0.91
A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2013) 0.90
Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS One (2014) 0.87
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. Qual Life Res (2014) 0.86
Plasma interleukin-6 and fatigue in terminally ill cancer patients. J Pain Symptom Manage (2007) 0.86
Cancer-related fatigue in breast cancer patients: factor mixture models with continuous non-normal distributions. Qual Life Res (2014) 0.86
Better postdiagnosis diet quality is associated with less cancer-related fatigue in breast cancer survivors. J Cancer Surviv (2014) 0.85
Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol (2013) 0.85
Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. J Neurooncol (2014) 0.84
Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer. J Pain Symptom Manage (2013) 0.84
Systematic review and meta-analysis of interventions for postoperative fatigue. Br J Surg (2002) 0.83
Survivorship: fatigue, version 1.2014. J Natl Compr Canc Netw (2014) 0.81
Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors. Cancer (2013) 0.81
Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials. Complement Ther Med (2014) 0.77